iqukikofor.wordpress.com
The money was grantedc in collaboration withthe U.S. Army Medicaol Research and Materiel Command and the throughthe Ft. Detrick Technology Transfer Initiative. The purpose of the technology transfe r program is to raise awareness of new and developin technologies and funding them to transition as viablse projectsfor follow-on funding in the marketr place. Each company that received fundiny was awardedapproximately $50,000 between March 2008 and May making up the initiative’s second round of financia awards since its $750,000 prograk extension. The funds for the program’s seconf phase were secured by Sen. Barbara Mikulski, and Rep. Roscoe G. Bartlett, “The [Ft.
Detrick Technology Transfer Initiative] program is enabling area businessees to harness the technologiez being developed at Fort Detricki and apply them to the commercial said Mikulski. “This will lead to new products that have the powe to create jobs andsave lives.” Mikulskik announced the first phase of the tech transfet program in March 2005 when 11 companied received funding. in Rockville: The company is developing a healty care technology called miTag which is a scalable wireless sensor solution for improvingfpatient flow.
in Frederick: The company is developintg a technology called the GeNova Screento isolate, and produce antibody-like in Rockville: The company is developingg an on-demand biotech products includingh a combination vaccine against plague and BioAssay Works LLC in The company is developing a lateral-flow visual diagnostivc test to detect and differentiate single sample multiplwe pathogenic poxviruses, including variola, and monkeypox. in Catonsville: The company is safety-testinv a medical product called which isa non-compressible, intracavitary hemostatix agent.
CynerGene IDMP in Frederick: The company is developing, validatinv and implementing a supplemental diagnosisof Malaria, HIV, and Dengude using its Infectious Disease Multiple Panel approach, which could allow for creatiojn of biosensors. LLC in Baltimore: The company is developingy required components and system framework to enabled conversational interfaces fortelemedicine tools. Such tools wouldx allow professional medics touse voice, gesture, and other human- computer interactions to access and document information in electronic medicapl records.
in Rockville: The company is developinv technology to preserve mammalian cells in dried formaty that can easilybe re-hydrate d for a variety of uses. LLC in The company is evaluating the effect of Imagilihn patented probiotics as a food supplemenyt to enhance the immune responsiveness of guinea pigs upon immunizatiom or challenge with virulent The evaluation will suggest the ability of Imagili patented probiotics to enhance the immunizationb ofa vaccine. in Baltimore: The companyu is developing micropatterned substrates for viralinfectivith assays. Juxtopia in Baltimore: The company is customizinhg its Wearable Assistance and SituationaplAwareness (WASA) goggles and service to alloe U.S.
Army combat medics to access and documenr information to electrical medical recordsvia hands-free voice-requests and in Baltimore: The companyu is developing cell therapies to treat brain and spinak cord injuries.
Saturday, July 23, 2011
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment